Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Xiaoji Tongbian Fang is a Traditional Chinese Medicine (TCM) herbal formula specifically developed for the treatment of pediatric functional constipation and food accumulation syndrome (Ji Zhi). The formula typically comprises a synergistic blend of botanical ingredients, including *Rheum palmatum* (Da Huang), *Magnolia officinalis* (Hou Po), *Citrus aurantium* (Zhi Shi), and *Crataegus pinnatifida* (Shan Zha). Its therapeutic mechanism involves promoting gastrointestinal motility, resolving food stagnation, and modulating the intestinal microbiota to facilitate regular bowel movements. It is frequently utilized in clinical pediatric practice in China, often as a hospital preparation, to alleviate symptoms such as abdominal distension, hard stools, and anorexia. Clinical research, including randomized controlled trials registered in the Chinese Clinical Trial Registry, has evaluated its efficacy and safety profile in children compared to conventional osmotic laxatives.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Xiaoer Xiaoji Tongbian Fang.